Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Omar Emiliano Aparicio‐Trejo, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 65-81
Closed Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

Animal models of chronic kidney disease: The missing piece of the puzzle for the development of new therapeutic options
Miloš Ilić, Dušanka Stanić, Milica Kravljača, et al.
Arhiv za farmaciju (2025) Vol. 75, Iss. 2, pp. 148-166
Open Access
Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice
Chetan Ram, Shobhit Gairola, Abu Mohammad Syed, et al.
Life Sciences (2022) Vol. 298, pp. 120527-120527
Closed Access | Times Cited: 18
Rosmarinic acid ameliorates renal interstitial fibrosis by inhibiting the phosphorylated-AKT mediated epithelial–mesenchymal transition in vitro and in vivo
Yi‐Hsien Hsieh, Jen‐Pi Tsai, Yi-Hsuan Ting, et al.
Food & Function (2022) Vol. 13, Iss. 8, pp. 4641-4652
Closed Access | Times Cited: 17
Reno-protective effect of protocatechuic acid is independent of sex-related differences in murine model of UUO-induced kidney injury
Karim M. Saad, Évila Lopes Salles, Sahar Emami Naeini, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 1, pp. 98-111
Closed Access | Times Cited: 3
Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Qi Yan Nan, Shang Guo Piao, Ji Zhe Jin, et al.
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 5, pp. 586-599
Open Access | Times Cited: 3
Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction
Shobhit Gairola, Chetan Ram, Abu Mohammad Syed, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174479-174479
Closed Access | Times Cited: 22
Hierarchically structured microcapsules for oral delivery of emodin and tanshinone IIA to treat renal fibrosis
Jiang Sun, Zhishi Xu, Yu Hou, et al.
International Journal of Pharmaceutics (2022) Vol. 616, pp. 121490-121490
Closed Access | Times Cited: 14
The angiotensin receptor neprilysin inhibitor LCZ696 attenuates renal fibrosis via ASK1/JNK/p38 MAPK-mediated apoptosis in unilateral ureteral obstruction
Jun Ding, Sheng Cui, Song Yu Li, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0286903-e0286903
Open Access | Times Cited: 9
Tongluo Yishen Decoction Ameliorates Renal Fibrosis via Regulating Mitochondrial Dysfunction Induced by Oxidative Stress in Unilateral Ureteral Obstruction Rats
Jia Qi, Han Lin, Xiaoyu Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 20
Relationship between ferroptosis and mitophagy in renal fibrosis: a systematic review
Mingyu Zhang, Ziyuan Tong, Yaqing Wang, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 8, pp. 858-866
Closed Access | Times Cited: 7
C3aR contributes to unilateral ureteral obstruction-induced renal interstitial fibrosis via the activation of the NLRP3 inflammasome
Danyu You, Mengjie Weng, Xiaoting Wu, et al.
Life Sciences (2022) Vol. 308, pp. 120905-120905
Closed Access | Times Cited: 12
Carvacrol preserves antioxidant status and attenuates kidney fibrosis via modulation of TGF-β1/Smad signaling and inflammation
Chetan Ram, Shobhit Gairola, Abu Mohammad Syed, et al.
Food & Function (2022) Vol. 13, Iss. 20, pp. 10587-10600
Closed Access | Times Cited: 12
Oxidative stress and NRF2 signaling in kidney injury
Carl K.‐Y. Ng, M. Kim, Yanti Yanti, et al.
Toxicological Research (2024) Vol. 41, Iss. 2, pp. 131-147
Closed Access | Times Cited: 2
Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products
Wei Tan, Yunyan Wang, Hongmei Dai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Investigation into the effect and mechanism of dapagliflozin against renal interstitial fibrosis based on transcriptome and network pharmacology
Yuyuan Liu, Yanzhe Wang, Sijia Chen, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109195-109195
Closed Access | Times Cited: 11
Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
Chiaki Kawabata, Yosuke Hirakawa, Reiko Inagi, et al.
Physiological Reports (2023) Vol. 11, Iss. 14
Open Access | Times Cited: 6
Involvement of NADPH oxidases in the Na/K‑ATPase/Src/ROS oxidant amplification loop in renal fibrosis
Huimin Zhang, Fangfang Lai, Xi Cheng, et al.
Molecular Medicine Reports (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 5
Breast Milk Mesenchymal Stem Cells and/or Derived Exosomes Mitigated Adenine-Induced Nephropathy via Modulating Renal Autophagy and Fibrotic Signaling Pathways and Their Epigenetic Regulations
Tarek Khamis, Amira Ebrahim Alsemeh, Asma Alanazi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2149-2149
Open Access | Times Cited: 5
Therapeutic application of traditional Chinese medicine in kidney disease: Sirtuins as potential targets
Qi Jin, Tong‐Tong Liu, Fang Ma, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115499-115499
Open Access | Times Cited: 5
Sulforaphane protects from kidney damage during the release of unilateral ureteral obstruction (RUUO) by activating nuclear factor erythroid 2-related factor 2 (Nrf2): Role of antioxidant, anti-inflammatory, and antiapoptotic mechanisms
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Isabel Amador‐Martínez, et al.
Free Radical Biology and Medicine (2023) Vol. 212, pp. 49-64
Closed Access | Times Cited: 5
The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-β/Smad and RAF/ERK Pathways
Xiaocui Feng, Jianfeng Zhang, Runling Yang, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 386, Iss. 3, pp. 310-322
Open Access | Times Cited: 4
Lipidomic study of kidney in a mouse model with urine flow obstruction
Divyavani Gowda, Md Abdul Masum, Siddabasave Gowda B. Gowda, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Antioxidants targeting mitochondria function in kidney diseases
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Isabel Amador‐Martínez, et al.
Mitochondrial Communications (2024) Vol. 2, pp. 21-37
Open Access | Times Cited: 1
Redox‐sensitive signaling pathways in renal cell carcinoma
Alfredo Cruz‐Gregorio, Ana Karina Aranda‐Rivera, José Pedraza‐Chaverrí, et al.
BioFactors (2021) Vol. 48, Iss. 2, pp. 342-358
Closed Access | Times Cited: 9
Glutamate ionotropic receptor NMDA type subunit 1: A novel potential protein target of dapagliflozin against renal interstitial fibrosis
Yuyuan Liu, Yanzhe Wang, Sijia Chen, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175556-175556
Closed Access | Times Cited: 3

Scroll to top